Pharma and MedTech look similar from the outside

Pharma and MedTech look similar from the outside. Inside, they're completely different worlds.

I've operated across both. 55+ countries. Different markets. Different pressures. And the question I still get asked is: how different can it really be?

Very different. Here's what I've learned.

In medical devices, trust is built through experience. Physicians can see it. Touch it. Watch it change a workflow in real time. The conversation starts fast. But long-term adoption is never guaranteed by the device alone.

In pharma, trust is built through data over time. The conversation starts slower. Clinical evidence, guidelines, outcomes. You're not selling something they can hold. You're shifting a belief.

But here's what most people miss. The biggest difference isn't speed. It's consequence.

In medical devices, decisions are visible, immediate, and often irreversible, clinically and commercially. That creates a completely different level of accountability. For the physician. For the team. For you.

The real inflection point in both worlds comes when clinical evidence, economics, service, and training align as a system. Especially in complex or emerging markets, where infrastructure, access, and trust don't come standard.

Pharma and devices both require skill. But they reward very different decision-making muscles. The risk is assuming success in one automatically translates to the other.

Different paths. Same end game: credibility with physicians and better patient outcomes.